Merial has announced the launch of V LINE, a new range of parasiticides sold exclusively through veterinary practices.
The first two products, called Broadline for cats and NexGard for dogs, will be unveiled at the BSAVA Congress at the start of next month.
Broadline is a broad-acting POM spot-on for cats containing eprinomectin, praziquantel, s-methoprene and fipronil, indicated for use against tapeworms, ticks, roundworms and fleas.
NexGard is a POM flea and tick control product for dogs given monthly as a palatable soft chew. It contains a novel active ingredient called afoxolaner which, according to Merial, has a new and distinct mode of action that provides a fast speed of flea kill.
Roddy Webster, Head of Pets at Merial said: "We are pleased to announce the launch of Broadline and NexGard. Merial is a market leader with a strong heritage in anti-parasitics and we have leveraged that expertise as well as our understanding of what pet owners want, to deliver these truly consumer-focused solutions. Such prescription-only innovations also demonstrate our ongoing commitment to the veterinary profession."
The veterinary group is stumping up more than £100,000 for the initiative, which will enable 20 vets and nurses, and 56 new grads from across the group to work with the Worldwide Veterinary Service (WVS) and other overseas animal charities.
The grants are for £1,500 and those taking part will also get up to one week of paid time off work whilst they volunteer.
VetPartners CEO Jo Malone said: “We wanted to support colleagues to have a fantastic experience while improving their skills in a different environment.
"It will give people a chance to use their clinical skills to give back to charities which are doing great work.
“If you’re working in a veterinary practice in Europe, you have support from team members around you and great facilities and equipment compared to the more challenging conditions working for a charity overseas.
"Working in these more challenging environments while they are volunteering will help build resilience, as our team members are unlikely to have experienced anything like this before.
“Charities like the World Veterinary Service are working ethically to help animals that may or may not have ever had veterinary care, and are doing a great job so we are delighted to support them.”
Ceva Animal health has launched Marbox, a broad-spectrum anti-infective, based on marbofloxacin, for the rapid treatment of bovine mastitis and respiratory disorders. According to the company, Marbox effectively provides two products in one bottle because it can be used as a high dose single injection or administered at a lower dose over several days.
Ceva says mastitis and respiratory disorders currently account for around 60% of antimicrobial prescriptions. Marbox can be used intramuscularly as a single injection for the treatment of respiratory infection. Alternatively it can be used for the treatment of acute mastitis; intravenously for the first injection and then subcutaneously at a lower dose over three days. It has a milk withdrawal of just 36 hours after subcutaneous injection.
Marbox is presented in an ergonomic CLAS vial which makes for light and shock-resistant handling, resulting in fewer breakages and reduced costs. It is available in 100 and 250 vial sizes and contains 100mg marbofloxacin per ml.
Marbox can be used in combination with Meloxidyl, Ceva's new, single shot anti-inflammatory. The product joins Ceva's bovine range of anti-infectives, which includes Cevaxel, Florkem and Spectam Injectable.
For further product information contact CEVA Animal Health Ltd, 90 The Broadway, Chesham, Bucks, HP5 1EG, telephone 01494 781510 or visit the website at http://www.ceva.uk.com/
Norbrook Laboratories Ltd has launched Propentofylline, a new product designed to reduce lethargy and improve general demeanour and exercise tolerance in older dogs.
Michelle Jones, Brand Manager at Norbrook said: "We launched Propentofylline to the UK market at the recent VPMA Congress where it was warmly received by the delegates with plenty of positive comments on both the lively design of the campaign and the opportunities for use of this product in practice. The product is indicated for improving dullness, lethargy and general demeanour in dogs to essentially give them a new lease of life."
Available in 50mg and 100mg tablets, Norbrook says Propentofylline can be prescribed to help boost a dog's willingness to exercise and improve exercise tolerance.
Speaking at the launch of the product at the VPMA Congress, Ms Pauline Graham, VPMA President from Capontree Vets said: "Propentofylline, as an active ingredient, is widely prescribed by vets with its properties that assist increased blood flow, particularly to the heart and skeletal muscle. Also increasing the blood flow to the brain and therefore its oxygen supply, it is a well recognised treatment for older, lethargic dogs to help encourage brightness as well as tolerance and willingness to exercise. I am pleased to see Norbrook offering this product as another high quality and cost-effective addition to their small animal range."
Michelle added: "Veterinary practices can avail themselves of a range of promotional support material for our Propentofylline product including a technical brochure and waiting room posters. We will also have an introductory offer which our Territory Managers will be pleased to discuss with their clients."
Virbac is offering a free Rapid Romanowsky stain kit and Coplin jars to practices buying easOtic and Epi-Otic in a new promotion which runs until the end of October.
easOtic is Virbac's treatment for otitis externa. It features a 1ml airless pump for precise measurement and an award-winning bottle design to aid compliance by ensuring easy and accurate application.
Epi-Otic is Virbac's antibacterial and antifungal ear cleaner for use in routine cleaning. It is pH neutral and contains sodium docusate, which dries the ear canal after application.
Practices making a qualifying purchase of both products will receive the Stain Kit, comprising the three staining solutions and three Coplin jars, free of charge.
For further information, contact your Virbac Territory Manager.
The Veterinary Capability and Capacity Project (VCCP) is co-chaired by the UK’s Chief Veterinary Officer Nigel Gibbens, RCVS Senior Vice-President Dr Chris Tufnell, and BVA Senior Vice-President Gudrun Ravetz. The project board also comprises the CVOs for Scotland, Wales and Northern Ireland, Sheila Voas, Christianne Glossop and Robert Huey, as well as the Animal and Plant Health Agency and the Food Standards Agency.
The project’s objective is to work with the veterinary sector to better understand the UK’s workforce needs and ensure that both the Government and veterinary businesses can continue to protect animal health and welfare, safeguard the food chain and maintain levels of public health and public services, and enable trade in animals and animal products.
The project will include a joint BVA-RCVS submission to the Migration Advisory Committee’s call for evidence on workforce issues post-Brexit. Three working groups have been set up within the project to look specifically at issues of veterinary resources, recruitment and retention.
The UK’s Chief Veterinary Officer, Nigel Gibbens, said: "Leaving the EU provides us with an opportunity to develop gold standard policies on animal welfare. The UK Government is determined to get a good Brexit deal for Britain and Ministers have been absolutely clear we will maintain our world-leading animal welfare standards.
"The VCCP is a great example of collaborative working between government, professional bodies and regulators to prepare for our exit from the European Union.
"I am pleased the Prime Minister has set out the government’s aim to secure the status of the veterinary workforce as a top priority as we leave the EU. The UK’s vets - both Official Veterinarians and those in the private sector - play a key role in protecting our country from endemic and exotic diseases, tackling outbreaks when they occur, safeguarding our animals and tackling global challenges like antibiotic resistance."
Chris Tufnell said: "Since the vote to leave the European Union last year the RCVS has been working in partnership with BVA to highlight to Government and others the potential workforce shortages that could arise from a loss of non-UK EU-qualified vets, particularly in public health work where they tend to predominate. Our position was highlighted in our Brexit Principles published earlier this year and at an event organised by us and the BVA at the Palace of Westminster for MPs and Peers.
"We are very glad that Defra is working proactively with us and BVA to understand the scale of the issues and map out the risks and opportunities and to help us plan for a number of different scenarios in advance so that we do not find ourselves in a position whereby animal health and welfare or public health might be compromised by workforce shortages."
BVA Senior Vice President Gudrun Ravetz said: "Vets provide the foundation for the UK’s high animal health and welfare, and make an essential contribution to the UK economy and wider society. Veterinary teams up and down the country support the UK’s 11 million pet-owning households; not a penny of the UK’s £12.7 billion livestock industry could be realised without vets; and vets are vital to facilitating UK trade, through health certification and controls, so that consumers have confidence in the food safety and welfare of the products they buy.
"Non-UK EU vets make up around 50% of our new workforce each year yet, since the EU referendum; we are facing increasing problems in recruiting and retaining EU colleagues to the UK. The impact of the loss of even a small percentage of the veterinary workforce could have serious repercussions on the practices, communities and industries that vets serve. This profession-wide project is pivotal to ensuring we have a veterinary workforce that can serve the UK’s needs post-Brexit."
The BVA’s Brexit and the veterinary profession report can be found at www.bva.co.uk/news-campaigns-and-policy/policy/future-of-the-profession/brexit/
To read the College’s Brexit Principles in full visit www.rcvs.org.uk/brexit
The Prime Minister has set out the government’s offer for EU citizens in the UK and UK nationals in the EU on their rights and status after the UK leaves the EU: https://www.gov.uk/government/publications/safeguarding-the-position-of-eu-citizens-in-the-uk-and-uk-nationals-in-the-eu
The government’s response to House of Lord’s EU Energy and Environment Sub-Committee’s inquiry into Brexit: Farm Animal Welfare also addresses veterinary capability post-Brexit:https://www.parliament.uk/documents/lords-committees/eu-energy-environment-subcommittee/Brexit-farm-animal-welfare/Gov-Brexit-farm-anim.pdf
For his research, Hugo visited the La Brea museum in Los Angeles, which gave him permission to study its collection of skeletal remains found in the La Brea tar pits.
“During my first visit, I concentrated on stifle diseases like cranial cruciate ligament rupture, which are very common in our modern-day dog companions.
"But in addition to cruciate disease, I also found OCD (osteochondritis dissecans) defects in the stifles and shoulders – which is again very common in modern dogs."
"My second visit was more focused on the changes in the spine of the dire wolf and the Sabre-toothed cat.”
"Some dire wolves had cruciate ligament ruptures, but it was uncommon compared to the most affected dog breeds.
"This is very similar to modern-day grey wolves which also suffer rarely from cruciate damage.
"In contrast, the prevalence of stifle OCD in these fossilised remains is amazingly high, especially in the sabre-toothed cat.
"This could indicate some degree of inbreeding, a factor which is predicated for species close to extinction.
“Malformations of the lumbosacral area are linked to inbreeding in modern grey wolves, and I found that the sabre-toothed cat also had a high prevalence of the same malformations we see in these wild modern inbred wolves, and some dog breeds today."
Hugo concluded: "The fact that some of the most common joint diseases in growing dogs can be found in the Ice Age under circumstances which could have caused inbreeding should alert pet owners and breeders to look out for inbreeding in our dog breeds.
"Careful evaluation and monitoring of dog breeding using DNA analysis could reduce painful joint damage."
Animal Health and Veterinary Laboratories Agency (AHVLA) has announced the formation of a new independent advisory group to recommend a future delivery model for veterinary surveillance in England and Wales.
The Advisory Group will be chaired by Dirk Pfeiffer, Professor of Veterinary Epidemiology at the Royal Veterinary College. According to the AHVLA, it will include representatives from government, the veterinary profession and the livestock farming and private laboratory industries and is being created so all those with an interest in veterinary surveillance can shape a future model and ensure that all issues are thoroughly considered.
Veterinary surveillance seeks to identify new or re-emerging threats to our livestock population and to public health. It involves a partnership approach between livestock keepers, private veterinary surgeons, the Scottish Agricultural College, industry bodies and AHVLA in order to effectively gather and assess intelligence.
AHVLA is seeking to identify ways to undertake veterinary surveillance both more effectively and at an affordable cost to the taxpayer. Work in this area has been on-going since 2010, and the merger of the former Animal Health and Veterinary Laboratories Agency (VLA) has created opportunities to review how veterinary surveillance can best be delivered.
The new model will aim to address capacity imbalances in the current service where provision sometimes outstrips demand. The independent advisory group are also expected to recommend how better and closer working methods across the partners can make the surveillance stronger as well as more cost effective.
Surveillance has historically been based on in-depth investigation of disease incidents with an emphasis on post mortem examinations carried out at AHVLA's regional laboratories. This system is a key element in the government's risk-based approach to the management of animal disease related threats.
AHVLA says that the current model, although successful in identifying diseases in the past, can be improved upon. A recent internal AHVLA report identified viable options for achieving better surveillance at the same or lower cost by, for example, exploring moving towards risk and intelligence based surveillance and improving the value added by working more closely in partnership with vets and their farmer clients and other sources of intelligence data.
In mid-January 2012, AHVLA will also be publishing, and publicising, an online survey aimed at individual veterinary practioners and livestock keepers. The survey will seek individual opinions on the inputs, mechanisms, outputs and value of surveillance in England and Wales Work is expected to run until spring 2012, following which recommendations on a way forward will be made.
Carl Padgett, President of the BVA, said: “Veterinary surveillance is an essential component in our animal health, public health, food security, and international trade work.
“The emergence of Schmallenberg virus in ruminants in northern Europe demonstrates the current value and ongoing need for a robust surveillance system to work both nationally and internationally.
“The BVA welcomes the establishment of the advisory group and particularly the wide range of veterinary expertise and experience that is represented on the group. It is important that views from both veterinary practitioners and veterinary scientists are fed into this review.
“While we understand that AHVLA and Defra must ensure value for money from the surveillance network, any future model must be shaped by good surveillance strategies, not the need to cut costs.
“We urge all practitioners in England and Wales to contribute to the discussions by completing the online survey.
“We look forward to engaging with the advisory group as it carries out the review and beyond.”
The move comes as the whole agriculture industry, co-ordinated by agricultural and food industry alliance RUMA (which promotes responsible use of medicines in farming), looks to build on the recent 10% reduction in use of antibiotics to treat farm animals.
The BCVA’s Dr Elizabeth Berry, who prepared the recommendations, said that whilst the responsible use of antibiotics has been promoted for many years across farming sectors, there is still the potential to reduce use in some areas and to move away from products which are important for human health.
She said: "This is an official position from BCVA to our members but we would like to see all in the cattle sectors embrace these recommendations in the understanding that we need to play our part in increasing responsible use of antibiotics.
"Work still needs to be done to establish the levels currently being used in cattle so that appropriate targets can be set but there are measures that can immediately be adopted.
"So we are recommending reducing both the overall amount of antibiotics used in cattle practice and minimising the use of the high priority CIAs – namely third and fourth generation cephalosporins, fluoroquinolones and colistin. These drugs should only be used where they have been demonstrated by sensitivity testing to be the only suitable choice to avoid unnecessary suffering."
The BCVA, which has over 1,100 practising members covering around 85% of vets working with cattle, is also recommending that use of antibiotics as a preventative treatment is avoided wherever possible as long as animal welfare is not compromised.
Dr Berry added: "Where preventative treatment – or prophylaxis – is used it should be regarded as an interim measure whilst alternative management or vaccination strategies are implemented.
"For example, all cows which comply with recommendations for using an internal teat sealant should be considered for non-antibiotic treatments at drying off."
The BCVA continues to advise that every farm should have a herd health plan which embraces all of the disease control strategies appropriate for disease reduction on that farm. In addition, farm management best practice should be followed, such as the guidelines issued by Red Tractor farm assurance.
Dr Berry says BCVA further recommends that all herds should establish their BVD status and eradicate the disease where it is found. "BVD can have a detrimental effect on incidence of many diseases and its eradication will have a significant impact on the need for antimicrobial use.
"We also continue to recommend the use of diagnostics to identify disease so that appropriate treatments can be selected and vaccination programmes instituted to prevent or reduce the severity of disease."
BCVA’s confirmation of its official position has been welcomed by RUMA. Secretary General John FitzGerald says that while RUMA’s promotion of responsible use over the past 20 years means the UK remains among the lower users of antibiotics in farming in Europe1, more needs to be done.
"The BCVA’s position is clear and leaves no doubt that action needs to be taken,” says Mr FitzGerald. “It is underpinned by science, recognising that banning preventative use outright or access to critically important antibiotics is not an answer. Both are important tools in fighting disease and preventing suffering so we still need them – but we need to use them more strategically and only when no other options exist."
The complete list of guidelines can be downloaded from the BCVA website www.bcva.eu.
The wellbeing room is designed to offer staff a comfortable space to relax during breaks, or before or after shifts. It has comfortable seating and a small library of books covering topics such as personal development, mindfulness and stress reduction.
There are also two 'jars of joy' staff can dip into which feature top tips for emotional, mental and physical wellbeing. Employees are also being invited to put forward their own top tips on wellbeing to share with colleagues.
It is hoped that the room will also provide employees with a sanctuary from social media, emails and telephones.
Sounds like a great idea to me, although the library titles look a bit uninspiring for my taste. My ideal wellbeing room would have a few John Grishams on the shelves, limitless music, a Sony playstation, oh, and a minibar.
The aim of the ‘Advocates of Knowledge’ CPD lungworm modules is to help vets assess the lungworm risk in their area, recommend prevention and treatment regimes and also to communicate effectively with clients as the UK emerges from lockdown.
In the first module, Dr Jenny Helm, European Specialist in Small Animal Internal Medicine and Senior Veterinary Clinician at the University of Glasgow, tackles questions about lungworm post lockdown, including whether or not pets are at greater risk as a result of changes in their owners' behaviour caused by the pandemic.
The second module, from Dr Simon Tappin, European and RCVS Recognised Specialist in Small Animal Internal Medicine, and Head of Medicine at Dick White Referrals (pictured right), will take the form of an interactive case-based discussion on lungworm. He will use clinical cases to talk through presenting signs, and how to approach investigation of these cases, as well as looking at treatment and prevention strategies.
Vicky McAlister, Senior Brand Manager for Advocate, said: “During lockdown, dog owners have modified their behaviour (including spending more time outdoors with their dogs), and this may have affected the risk of dogs becoming infected with lungworm. So we’re very pleased that, together with our experts, we’re launching informative, engaging and relevant CPD lungworm modules for vets, to help provide them with the information needed, and importantly to encourage communication with dog owners regarding this important subject matter”.
You can sign up for the CPD modules here - https://advocatesofknowledge.vettimes.co.uk.
The lives of pet rabbits in Britain, the UK's third most popular pet, are being drastically cut short due to owners' ignorance and misinformation, according to a survey for Rabbit Awareness Week (26th April - 2nd May 2010).
The survey revealed a widespread lack of knowledge about what pet rabbits need to live longer, healthier and happier lives. Almost half of the respondents believe that vegetables, fruit and carrots are the most important food for rabbits. In addition, 71% didn't know that fibre, in the form of hay and grass, is the most important food for rabbits, without which they can die.
More than 50% of those surveyed did not know that rabbits should be kept in pairs, and 90% of respondents didn't know that owning a rabbit is likely to cost more than £3,000 over the course of its lifetime.
Sean Wensley, senior veterinary surgeon at the PDSA, said: "Despite more than a million pet rabbits currently being kept across the country, the results of this survey add to our concerns that their welfare needs are sadly misunderstood.
"It is vital that owners understand the commitment involved in owning pet rabbits, both financially and in terms of the time taken to care for them properly. It is also essential that owners understand their rabbits' welfare needs, including their need to be fed a suitable diet, to have a large hutch and exercise run, to have company and to receive appropriate health care, including vaccinations against deadly diseases."
For more information, see: http://www.rabbitawarenessweek.co.uk
The RCVS Disciplinary Committee has accepted an application for restoration to the RCVS Register by James Main, who was struck off in 2011, following his administration of a prohibited substance to a racehorse and his subsequent attempts to conceal his actions.
At a Disciplinary Committee hearing held on 22 February 2011, Mr Main, a partner in the O'Gorman, Slater, Main & Partners veterinary practice in Newbury was found guilty of serious professional misconduct and his name was removed from the Register. The then-Committee established that, contrary to the British Horseracing Authority's (BHA) rules of racing, Mr Main had injected tranexamic acid into the racehorse 'Moonlit Path' on 19 February 2009, knowing that the horse was to race later that day. He was also found guilty of dishonestly concealing this injection in his practice records as a "pre-race check".
At yesterday's hearing, the Committee noted that the decision to remove Mr Main from the Register had sent a clear message to the profession of the importance of strict compliance with the BHA's Rules of Racing; it was the inevitable consequence of his breaches of those rules and his dishonesty in concealing the administration of the injection. In oral evidence, Mr Main said he accepted the findings and decision of the previous Committee, and he apologised.
The Committee also noted a number of changes since implemented at Mr Main's practice, including a pharmacy review to improve traceability of drugs; withdrawal of the use of tranexamic acid in the management of Exercise Induced Pulmonary Haemorrhage; and a cautious approach to drug withdrawal times. Mr Main's practice had also reviewed its processes to ensure its veterinary surgeons complied with all relevant rules, regulations and guidance, and that any requests by clients to breach these rules would be refused.
The Committee accepted evidence that Mr Main had worked in a management capacity in his practice since 26 March 2011, performing no clinical role, and had undertaken appropriate continuing professional development since being removed from the Register. It also noted the large volume of testimonials and public support presented at the hearing from both veterinary surgeons and clients in the horse world.
Furthermore, it noted that removal had been financially and emotionally detrimental to Mr Main, his family and practice and, if his name were not restored to the Register, there would be a continuing detrimental effect on his family finances and the practice.
Committee Chairman Professor Peter Lees said: "The Committee accepts that Mr Main has found the removal of his name from the Register a humbling and salutary experience and accepts his apologies. It is satisfied that he is very unlikely to breach the rules of racing in the future and does not consider that there is a risk to the future welfare of animals by restoring his name to the Register.
"The Committee does not consider that any further period of erasure would be of benefit either to the public or the veterinary profession."
The Committee directed that Mr Main's name be restored to the Register.
The RCVS has published the conclusions of The McKelvey Report, a review into the circumstances leading to a substantial overspend on the College's new database and development works at Belgravia House.
The review was carried out by Professor Bill McKelvey - a member of the College's Governance Review Group - and two of the College's Privy Council-appointed Council members to consider all aspects relating to the College's budgeting and expenditure process, and propose lessons that could be learned.
Whilst the full report has not yet been published, its conclusions highlight:
Overall, the report concluded that:
Weaknesses exist in the governance of the RCVS which pose significant risks to the proper conduct of its business. Executive staff have not been provided with a robust governance framework by the Council, and this has led to a number of unnecessary misunderstandings between Executive staff and Non Executive members of Council. These matters should be urgently addressed by Council in order to ensure that the confidence of ordinary members of the profession in their College can be restored.
Dr Jerry Davies, RCVS President said: "That such a review was required is regretted, but I would like to thank Professor McKelvey, Richard Davis and Judith Webb for their diligence in this work. Their recommendations will be a very helpful addition to the work that is currently underway to ensure corporate governance is fit for purpose and, in particular, that the management of capital projects within the College is optimised."
The full report is available here.
Animalcare Ltd has launched Marbocare (marbofloxacin) 100mg/ml solution for injection, a third-generation fluoroquinolone for the treatment of E.coli mastitis and bovine respiratory disease (BRD) in cattle, and Metritis Mastitis Agalactia in pigs.
The company highlights the product's unique flexible dosage regimen of once daily injections for 3 days against E.coli mastitis and BRD, plus a single intramuscular (IM) high dose (8mg/100kg) for BRD.
Animalcare says this regimen, coupled with the flexibility of administration afforded by all three injection routes (intravenous IV, subcutaneous SC and IM), a low volume dose and good syringeability, all combine to offer ease of use; resulting in a reduction in handling and less stress for the cattle.
Developed for veterinary use only, Marbocare has broad spectrum activity against Gram+ve and Gram-ve pathogens. Animalcare says the product is especially effective against E.coli mastitis and the key bacterial pathogens associated with BRD, as well as M.bovis.
Marbocare has milk withdrawal times of 36 hours after the last treatment following the 3 day course and 72 hours after a single shot for BRD. Meat withdrawal is 6 days after multiple injections and 3 days after the single shot.
Marbofloxacin has proven efficacy in a comparative international, multi-centre, controlled, randomised field trial1 in 62 dairy cows with E.coli mastitis. Marbofloxacin cure rates were significantly higher than the control product. In respiratory disease it showed a more rapid clinical response in comparison to tilmicosin2, ceftiofur3 and oxytetracycline4. Marbofloxacin was shown to be well tolerated, leading to a fast return to appetite, liveweight gain and associated welfare benefits.
Marbocare is also licensed in the treatment of Metritis Mastitis Agalactia syndrome in pigs, given by IM injection, with a 4 day meat withdrawal.
Tony Liepman, Product Manager from Animalcare said: "Marbocare is competitively priced whether used on its own or alongside a single-dose anti-inflammatory such as Emdocam (meloxicam)."
Marbocare is a POM-V licensed product presented in 50 and 100ml multi-dose vials.
References
BVA has added its voice to the Labelling Matters campaign for the introduction of mandatory method of production labelling of meat and dairy products. This would help consumers across the UK to answer the simple questions "How was this animal kept?" and "Did this animal die a humane death?", including stunning before slaughter.
A key element of the Labelling Matters campaign is that mandatory method of production labelling must be underpinned by robust welfare outcome safeguards, with on-farm welfare assessments ensuring that high welfare standards are being achieved.
Legislation for mandatory method of production labelling has been implemented already for shell eggs, which must legally be labelled either as “eggs from caged hens”, “barn eggs”, “free range” or “organic”. Labelling Matters wants to see this principle extended to meat and dairy products from other farmed animals.
The BVA highlights evidence which shows that consumers in the UK and across Europe want clear food labelling with information about animal welfare:
BVA President Sean Wensley said: "For vets it's a top priority that the animals we rear for food have a good life and a humane death. Research shows that vets are not alone in caring about where their food comes from. Mandatory method of production labelling makes sense on a number of fronts: consumers can be clearly and consistently informed about how the animals reared for their meat and dairy products were kept, with on-farm welfare assessments assuring high standards. Mandatory method of production labelling would give unambiguous information to the high numbers of consumers who care about animal welfare when buying meat and dairy products and help ensure market support for British farmers who pride themselves on achieving the highest welfare standards."
Expanding on the training available in autumn 2022, which was launched based on the results of an extensive training pilot, MMI is offering a total of 14 sessions taking place both online and in person over the next few months. Sessions will be running from January to April 2023. The courses will cover areas that have been identified as priority topics from previous MMI surveys, feedback from the professions, and evaluation of the training pilots.
Mind Matters Initiative Manager, Lisa Quigley, said: “Mental health and wellbeing are impacted by a whole host of structural and societal factors and maintaining a healthy workforce goes far beyond supporting people on an individual level.
"Whilst it is undoubtedly important to provide people with the skills they need to look after themselves, we are aiming to expand on this by providing individuals with the skills and knowledge needed to recognise and address wider collective issues. For example, the importance of creating and maintaining a positive workplace culture.
Session dates and specific topics are as follows:
Mental Health First Aid (£30 in-person)
9am – 5pm
Psychological Safety and Civility (£20 in-person, £15 online)
In-person – 9am – 4pm
Online – 9am – 1pm
Sustaining Your Emotional Health (£15 in-person)
2pm – 5pm
For more information on the training courses, visit: https://vetmindmatters.org/training/
The Veterinary Marketing Association has announced a Practice Marketing Award, with a prize of £500 worth of CPD, for which entries are now being sought.
The award, which is sponsored by Merial, is open to companion and farm animal practices that can demonstrate effective marketing to their clients during the course of 2012.
For more information, visit: www.vma.org.uk/awards, or email: secretary@vma.org.uk for entry details.
BPEX is looking for a few more veterinary surgeons to test its Real Welfare smartphone app, which is used to collect data regarding welfare outcomes in pigs.
BPEX says it will pay vets for their time carrying out the testing but it needs regular submissions of data to give both Android and iOS a good workout.
Project Manager Katja Stoddart said: "It has been a long and sometimes difficult journey but the app is now performing well on both platforms and we are receiving positive feedback from those using it.
"That does not mean there are no problems but those that do crop up are now minor and can easily be dealt with.
"We still need a handful more vets willing to do the testing but we must stress we need regular data submission to make it worthwhile."
Ultimately the app will replace the bureau service which has only been extended until the end of this year so vets will need to change over before the bureau closes.
Katja said the portal will continue so vets can do the assessments in paper form then transfer via a computer but it will be much quicker and easier in the long run to input in real time using the app.
She added: "This will also mean the data is available immediately for the vet to discuss with the producer."
The company says it has been working hard to ensure improved supply on a number of brands including Apoquel, Palladia and now Trocoxil, with animal welfare being the key consideration at all times throughout this process.
Ned Flaxman, business unit director for companion animal, equine and innovation at Zoetis said: “It was a really difficult decision to stop production of Trocoxil in favour of Apoquel and Palladia but we felt that it was the right thing to do on animal welfare grounds. As soon as we had full stocks of these products we resumed the manufacture of Trocoxil and I am delighted to say that it will be back in stock in December.
"I would like to thank our veterinary clients for their patience and reassure them that we brought the product back to market as quickly as we could and do not anticipate any further stock issues."
Trocoxil chewable tablets are used for the treatment of pain and inflammation associated with degenerative joint disease in dogs aged 12 months or over.
For more information, contact your Zoetis account manager.
The traditional approach is to use anatomical knowledge to inject pain relief in the area of the nerves to be blocked.
Liz is leading a move away from this approach to a more precise method which uses ultrasound guidance to visualise the nerves, allowing the local anaesthetic to be placed directly around the nerve itself.
For some nerve blocks, it is possible to block just the sensory branches of nerves, which means pets can walk better immediately after surgery while not feeling any pain.
Liz, a past president of the Association of Veterinary Anaesthetists, said: “Local analgesia is now at the forefront of our post-operative care and reliably improves the quality of a pet’s recovery and reduces the need for opioid pain relief, which can cause side effects.
“We’re using the latest techniques to deliver the nerve-blocking anaesthetics to exactly where they’re needed.
“For many of the nerve blocks, the use of ultrasound guidance allows more precise delivery and a complete blockade of the sensory nerves, which is why, here at Paragon, we’ve invested in state-of-the art ultrasound machine designed specifically for superficial and deep nerve blocks.
“This means we can provide more effective immediate post-operative analgesia for our patients and minimise the need for further pain killers.
“The nerves can be directly visualised and local anaesthetic directly placed around the nerve bundles.”
Liz is keen to highlight the advantages of the increased use of local anaesthesia in the treatment of animals. She added: “We’re hoping we’ll soon be able to publish some clinical research on the use of some of the blocking techniques used to demonstrate our clinical impression of their effectiveness in patient management.”
The theme this year is 'The ever-complex cat: a multidisciplinary approach to feline medicine', around which there will be a full programme of talks and lectures, including more than 30 hours of CPD.
The main strands for each day are:
Keynote speaker Professor Kenneth Simpson, BVM&S, PhD, Chief of the Section of Small Animal Internal Medicine at Cornell University will deliver a series of talks on his specialisms, including gastrointestinal (GI) disease, pancreatitis and liver enzyme interpretation.
Joining him are more than twenty international feline experts who will be considering the cat from all angles, from imaging and clinical pathology to histology.
Nathalie Dowgray, Head of ISFM, said: "We are very excited about the line-up of speakers for this year’s congress, it is a fantastic opportunity for vets to understand the complexity of feline medicine and come away better able to manage difficult cases."
New for this year are live panel sessions in which delegates will be able to join the speakers in expert discussion on key feline topics, as well as opportunities to network and chat directly with leading names in the veterinary industry.
Delegates will also have access to all of the content for six months of on-demand learning after congress ends.
Registration is open now and available at a special early bird rate until March 31st. This year there are bursary places available for veterinary surgeons and students from low-income countries. More information about eligibility and how to apply can be found on the website.
To register, visit: https://icatcare.org/events/isfm-world-feline-congress/
At the meeting, Simon Biles from Moore Scarrott gave a 30 minute presentation, which was followed by a one hour discussion.
The recording can be watched on VetSurgeon.org here https://www.vetsurgeon.org/001/nonclinical/m/meetings/138080, where you can also claim the time watching towards your annual CPD requirement. Press the 'Claim CPD' red button in the title bar towards the top.
To make it easier to find content that interests you, there are markers on the video timeline.
There is also a forum thread on vetsurgeon.org for further discussion of any of the points raised in the film. See: https://www.vetsurgeon.org/001/nonclinical/f/site-support-discussions/29784/vetsurgeon-zoom-ir35-locums-and-umbrella-companies
For more information about Moore Scarrott, visit: https://www.moore-scarrott.co.uk
The researchers say that the findings pave the way to generating new and important information about the development chronic kidney disease (CKD) and hypertension (HTN) in cats.
The RVC says that about 30% of cats aged 10 years or older have CKD, which equates to approximately 600,000 in the UK.
Of these, about 40% will also have hypertension.
The research team was led by principal investigator at the RVC, Dr Rosanne Jepson, alongside joint first author from Queen Mary University of London, Dr Helen Warren, and Professor Patricia Munroe.
The team examined the archives of 1,022 domestic cats seen at both the RVC’s Beaumont Sainsbury Animal Hospital and Bow PDSA Pet Hospital since 1992, looking for genetic associations with CKD and HTN using a genome-wide association study (GWAS) approach.
The GWAS approach used a special feline array to characterise over 63,000 genetic differences across the feline genome.
The team examined the influence of different genes on disease traits which may point to new ways of treatment as the pathways and proteins controlled by these genes can indicate novel mechanisms for disease development.
Researchers say that this study method has historically been used for rarer and breed-specific conditions where single genetic mutations might be occurring.
However, the findings show it could now be used to generate new information about common and complex diseases which are likely to be the result of genetic, lifestyle and environmental risks.
Rosanne Jepson, Principal Author of the paper and Associate Professor in Small Animal Internal Medicine at the RVC, said: “This was an exciting opportunity to explore potential genetic influences on the development of chronic kidney disease and systemic hypertension in cats, collaborating with key opinion leaders who work and have published extensively in this field in human medicine.
“These conditions are complex - meaning that there are many factors relating to genetics, lifestyle and environment that cumulatively determine whether an individual may develop either CKD or hypertension in their lifetime.
“This study has shown us, as proof of concept, that large scale genomic studies will be important for understanding the pathogenesis of such complex disease conditions and may help to identify novel pathways as targets for diagnosis and management in the future.”
The two cases came from Bristol and Kingsbridge, Devon, taking the total number this year to five countrywide.
David Walker, American, RCVS and EBVS European specialist in small animal internal medicine, who leads the team at Anderson Moores, said: “We’re very sad to confirm two further cases of CRGV.
"Unfortunately, we find ourselves at the time of year when cases are most commonly identified."
There were 47 confirmed cases in 2020 and 28 in 2021.
The two new cases bring the total to 284 since the disease was first detected in the UK in 2012.
Anderson Moores has launched a website dedicated to Alabama Rot, which offers advice and information for owners and veterinary professionals, including a live map of confirmed cases across the UK: www.alabama-rot.co.uk.